Clinical Trials Directory

Trials / Unknown

UnknownNCT06074809

RCT on the Treatment of Menopausal Syndrome With Chinese Medicine

Clinical Trial on the Treatment of Menopausal Syndrome With Chinese Medicine Gui-zhi-fu-ling-wan With Variation and the Mechanism of Anti-inflammation and Body Surface Temperature Distribution

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
78 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
Female
Age
40 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This is a double-blinded, randomized, placebo-controlled clinical trial. Subjects will be randomly assigned to the treatment group (Modified Guizhi Fuling granules) or placebo group (Placebo granules) for 8 weeks. Outcomes will be measured at week 8 and week 12.

Detailed description

Menopausal syndrome is a series of symptoms caused by ovarian follicles degeneration that occurs before or after menopause. These symptoms include central nervous system-related disorders (such as hot flashes, insomnia, depression, anxiety, etc.); metabolic, weight, cardiovascular and musculoskeletal changes; urogenital and skin atrophy; and sexual dysfunction. Some previous studies have investigated the possibilities of using traditional Chinese medicine (TCM) for the treatment of menopausal syndrome. However, due to the limitations of previous clinical research, more evidence is required to support the efficacy of TCM treatment. Therefore, we propose to conduct a randomized, double-blinded, placebo-controlled clinical trial here, with the hope of objectively assessing the efficacy and safety of using TCM to treat menopausal syndrome.

Conditions

Interventions

TypeNameDescription
DRUGModified Guizhi Fuling granulesModified Guizhi Fuling granules will be orally administered to patients in the TCM treatment group twice a day throughout the treatment period, which lasts for 8 weeks.
OTHERPlaceboPlacebo will be orally administered to patients in the placebo group twice a day throughout the treatment period, which lasts for 8 weeks.

Timeline

Start date
2023-11-01
Primary completion
2025-10-31
Completion
2026-01-31
First posted
2023-10-10
Last updated
2023-10-10

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06074809. Inclusion in this directory is not an endorsement.

RCT on the Treatment of Menopausal Syndrome With Chinese Medicine (NCT06074809) · Clinical Trials Directory